GPR30 and Migraine: Estrogen Link Still Lacks Human Trials
A 2026 review argued that G protein-coupled receptor 30 may connect estrogen signaling, trigeminal pain pathways, and migraine biology, but migraine-specific human trials of GPR30-targeted drugs are still missing. Research Highlights The migraine rationale is hormone-linked: women have roughly 2 to 3 times the migraine prevalence of men, and 50% to 60% of women with …